Metraipolis › archive › dc_f67290ecd670

Lenacapavir for HIV Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences — Europe PMC PMID:40202860

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40202860
DOI
10.1093/cid/ciaf116
License (as archived)
solo-consultazione
Archived
2026-11-09T16:23:16.941Z
SHA-256 of the archived text
c963bc282490f465a1fa85653ef06cb3155cae712219dc45a9159439398325dd
Stable URL of this page
https://metraipolis.com/documento/dc_f67290ecd670

How to cite

Lenacapavir for HIV Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences — Europe PMC PMID:40202860 — Europe PMC (en), https://europepmc.org/article/MED/40202860 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f67290ecd670 (Metraipolis archive dc_f67290ecd670, sha256 c963bc282490f465a1fa85653ef06cb3155cae712219dc45a9159439398325dd)
BibTeX
@misc{dcf67290ecd670,
  title = {Lenacapavir for HIV Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences — Europe PMC PMID:40202860},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40202860},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f67290ecd670; sha256 c963bc282490f465a1fa85653ef06cb3155cae712219dc45a9159439398325dd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40202860. Agents can read the archived copy with the MCP tool read_document.